89483-08-9 Usage
Description
(R)-2-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid is a versatile organic compound belonging to the class of N-acyl-alpha amino acids. It is a derivative of L-alanine, characterized by a cyclopropyl group, an amino group protected by a tert-butoxycarbonyl group, and a carboxylic acid group. (R)-2-((tert-butoxycarbonyl)aMino)-3-cyclopropylpropanoic acid plays a significant role in medicinal chemistry and pharmaceutical research due to its potential therapeutic properties, such as anti-inflammatory and analgesic effects.
Uses
Used in Pharmaceutical Research:
(R)-2-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid is used as a building block in the synthesis of various peptides and other biologically active compounds. Its unique molecular structure allows for the development of new drugs with potential therapeutic applications.
Used in Medicinal Chemistry:
(R)-2-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid is utilized for its potential therapeutic properties, including anti-inflammatory and analgesic effects. Its versatility in the design and synthesis of pharmaceuticals makes it an important chemical in the field of medicinal chemistry.
Used in Drug Development:
In the pharmaceutical industry, (R)-2-((tert-butoxycarbonyl)amino)-3-cyclopropylpropanoic acid is used as a key component in the development of new drugs. Its ability to be incorporated into various peptide structures and its protective tert-butoxycarbonyl group make it a valuable asset in creating effective and targeted medications.
Check Digit Verification of cas no
The CAS Registry Mumber 89483-08-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,4,8 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 89483-08:
(7*8)+(6*9)+(5*4)+(4*8)+(3*3)+(2*0)+(1*8)=179
179 % 10 = 9
So 89483-08-9 is a valid CAS Registry Number.
89483-08-9Relevant articles and documents
TRIAZOLE-PYRIDINYL SUBSTITUTED AZACYCLOHEXYL ACETIC ACID COMPOUNDS AS LPA RECEPTOR ANTAGONISTS
-
Paragraph 0235, (2022/02/28)
This application relates to novel substituted azacyclohexyl acetic acid compounds, their manufacture, pharmaceutical compositions comprising them, and their use as medicaments for treating a disease associated with dysregulation of lysophosphatidic acid receptors (LPA).
Inhibitors of cysteine proteases and methods of use thereof
-
Page/Page column 466-468, (2021/09/22)
The disclosure provides compounds with warheads and their use in treating medical diseases or disorders, such as viral infections. Pharmaceutical compositions and methods of making various compounds with warheads are provided. The compounds are contemplated to inhibit proteases, such as the 3C, CL- or 3CL-like protease. Exemplary compounds provided include Formula II-I, where R3, RB are provided herein:
ANTHELMINTIC DEPSIPEPTIDE COMPOUNDS
-
Paragraph 295-296, (2017/07/14)
The present invention provides cyclic depsipeptide compounds of formula (I) and compositions comprising the compounds that are effective against parasites that harm animals, including humans. The compounds and compositions may be used for combating parasites in or on animals including mammals and birds. The invention also provides for an improved method for eradicating, controlling and preventing parasite infestation in animals, including birds and mammals.
